Celyad to Present Updates on CYAD-01 at the American Association for Cancer Research (AACR) Annual Meeting 2018 – GlobeNewswire (press release)
GlobeNewswire (press release) |
Celyad to Present Updates on CYAD-01 at the American Association for Cancer Research (AACR) Annual Meeting 2018
GlobeNewswire (press release) MONT-SAINT-GUIBERT, Belgium, March 29, 2018 (GLOBE NEWSWIRE) — Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biopharmaceutical company focused on the development of CART-cell therapies, today announced that the company … |
